We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
TRANYLCYPROMINE MEDICIANZ (Medsurge Pharma Pty Ltd)
Product name
TRANYLCYPROMINE MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
145 (255 working days)
Active ingredients
tranylcypromine sulfate
Registration type
New generic medicine
Indication
[Trade name] is indicated for the treatment of symptoms of depressive illness especially where treatment with other types of antidepressants has failed. It is not recommended for use in mild depressive states resulting from temporary situational difficulties.